What is the Subureteral Transurethral Injection (STING) procedure and what is an ectopic kidney?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is the STING Procedure and What Does an Ectopic Kidney Mean?

STING Procedure

The STING procedure (Subureteral Transurethral INjection) is a minimally invasive endoscopic technique that involves injecting a bulking agent (0.2-0.8 ml) beneath the intravesical portion of the ureter to create a valve mechanism that prevents backward flow of urine from the bladder into the kidney (vesicoureteral reflux). 1

How It Works

  • The procedure uses cystoscopy to inject bulking material (historically Teflon/polytetrafluoroethylene, now more commonly dextranomer-hyaluronic acid copolymer [Deflux®] or polyacrylate-polyalcohol copolymer [Vantris]) into the submucosal space at the ureterovesical junction
  • This creates a "mound" that lengthens and supports the ureteral tunnel, preventing reflux 2
  • The injection can be performed using different techniques, with STING and HIT (hydrodistention implantation technique) being the two main approaches 2

Success Rates and Considerations

According to the most recent European guidelines, endoscopic injection has variable success rates depending on reflux severity 3:

  • Grade I-II reflux: 78.5% success with one treatment
  • Grade III: 72% success
  • Grade IV: 63% success
  • Grade V: 51% success
  • If the first injection fails, a second attempt has 68% success, and a third has 34% success
  • Overall aggregate success with one or more injections reaches 85% 3

Important Caveats

  • Success rates are significantly lower in duplicate collecting systems (50% vs 73% for single systems) and neuropathic bladders (62% vs 74% for normal bladders) 3
  • The procedure carries a risk of late ureteric obstruction, particularly with older materials like Teflon, which can cause giant-cell foreign-body granulomas requiring ureteric reimplantation years later 4
  • Modern bulking agents (Deflux® and Vantris) have different properties: Deflux is absorbable, easier to inject with lower obstruction risk but may lose efficacy over time; Vantris is non-absorbable, more difficult to inject with higher obstruction risk but potentially more durable 2

Ectopic Kidney

An ectopic kidney is a congenital anomaly where the kidney fails to ascend to its normal lumbar position during fetal development and remains in an abnormal location, most commonly in the pelvis. 5

Key Characteristics

  • Occurs in approximately 1 in 900 to 1 in 3,000-7,000 individuals 5, 6
  • Results from arrested migration during embryogenesis when the kidney normally ascends from the pelvis to the lumbar region
  • Can be simple ectopia (abnormal location on the same side) or crossed ectopia (ureter crosses the midline) 6

Clinical Significance

While often asymptomatic, ectopic kidneys are more susceptible to complications due to their abnormal positioning 5:

  • Ureteropelvic junction obstruction (UPJO) - the most common complication
  • Recurrent urinary tract infections
  • Stone formation
  • Vesicoureteral reflux
  • Abnormal vascular supply (often from iliac arteries rather than the aorta) 6
  • May present as a pelvic mass in adults 7

Diagnostic Approach

  • Ultrasound is the first-line imaging modality
  • Three-dimensional CT urography provides detailed anatomical information about the kidney's position, vascular supply, and any associated obstruction 6
  • DMSA scan or DTPA renogram assesses differential kidney function 7

Management Considerations

  • Treatment depends on whether the ectopic kidney is functioning and whether complications are present
  • For non-functioning ectopic kidneys with severe hydronephrosis, nephrectomy prevents long-term complications 7
  • For functioning kidneys with obstruction, minimally invasive approaches like laparoscopic pyeloplasty can be performed, though the abnormal anatomy and vascular supply require careful surgical planning 6
  • When treating vesicoureteral reflux in a solitary ectopic kidney, modified endoscopic techniques with guidewire assistance can be used to ensure precise injection placement and avoid complications 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.